ClinicalTrials.Veeva

Menu

PeRiOperative Medicine Platform Trial (PROMPT)

M

Monash University

Status and phase

Not yet enrolling
Phase 4

Conditions

Quality of Recovery (QoR-15)
Anaesthesia
Major Complications
Quality of Life
Surgical Site Infection After Major Surgery

Treatments

Drug: Intermediate inspired oxygen
Drug: Liberal inspired oxygen
Drug: Conservative inspired oxygen

Study type

Interventional

Funder types

Other

Identifiers

NCT07186634
2025-49324-130781

Details and patient eligibility

About

Our specific aims are to investigate whether conservative (≤30%), intermediate (50%), or liberal (80%) inspired oxygen during and immediately after surgery: Aim 1: Reduces surgical site infections (SSIs or "wound infections") and other healthcare-associated infections (pneumonia and sepsis). Aim 2: Reduces a pooled composite of serious postoperative complications, leading to a faster and more complete recovery after surgery, and thus increases "days alive and at home up to 30 days after surgery" (DAH30). Primary hypothesis: Liberal (80%) oxygen concentration delivered with anesthesia in patients undergoing major surgery reduces the incidence of SSIs after surgery compared to conservative (≤30%) or intermediate (50%) oxygen concentration. Secondary hypothesis: Hyperoxia (50-80%) delivered with anesthesia in patients undergoing major surgery increases the incidence of pulmonary and other complications after surgery compared to conservative (≤30%) oxygen concentration, resulting in fewer Days At Home (DAH). PROMPT enrolls patients undergoing elective or semi-elective surgery.

Full description

www.promptssi.org.au

Enrollment

7,800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

PROMPT - Inclusion Criteria:

  • Adult patient (≥18 years of age at time of admission)
  • Scheduled to undergo a surgical procedure involving a skin incision, with an expected duration of at least 2 hours, and a planned overnight hospital stay of at least 1 night (including, but not limited to, cardiac surgery, orthopedic surgery, obstetric, or gynecological surgery).

PROMPT - Exclusion Criteria:

  • ASA physical status 5 (moribund, not expected to survive with or without an operation)
  • Inability to provide informed consent
  • Previous participation in PROMPT within the prior 30 days.

DSA 02 - PROMPT - Exclusion Criteria:

  • ASA physical status 1 or 2
  • Undergoing cardiac surgery
  • Undergoing thoracic surgery if one-lung ventilation is required
  • Currently suspected or proven infection
  • Advanced lung disease requiring home oxygen therapy
  • Previous bleomycin therapy
  • Known or suspected pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

7,800 participants in 3 patient groups

Liberal inspired oxygen
Active Comparator group
Description:
FiO2 0.8; i.e. 80%
Treatment:
Drug: Liberal inspired oxygen
Conservative inspired oxygen
Active Comparator group
Description:
FiO2 ≤0.3 \[30%\]
Treatment:
Drug: Conservative inspired oxygen
Intermediate inspired oxygen
Active Comparator group
Description:
FiO2 0.5 \[50%\]
Treatment:
Drug: Intermediate inspired oxygen

Trial contacts and locations

1

Loading...

Central trial contact

Trisha Peel, PhD; Paul S Myles, DSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems